+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Allergy Immunotherapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • PDF Icon

    Report

  • 119 Pages
  • August 2022
  • Region: Global
  • Acute Market Reports
  • ID: 5707264
Description Jump to:

Industry Outlook

Allergy immunotherapy market accounted for a market value of US$ 1,953.1 Mn in 2020 and is projected to grow at a CAGR of 10.1% during the forecast period from 2022 to 2030. Allergy immunotherapy helps to prevent or minimize allergic reactions and provide long-term benefit to patients. This therapy helps to increase immunological tolerance and changes the course of disease due to which demand for immunotherapy is increasing globally.

Subcutaneous immunotherapy (SCIT) is highly demanded treatment for allergic rhinitis & asthma as it provides long-term relief to the patients

SCIT is an effective therapy against allergic diseases as it delivers symptomatic relief by altering the effect of allergic reaction by focusing the basic mechanism of immunology. Thus, in 2020 SCIT identified as the largest allergy immunotherapy type that is preferred and adopted by most of the physicians. In addition to that, compared with conventional treatment the cost-effectiveness of SCIT is high and new molecules under trials will assist the overall growth of allergy immunotherapy.

Air pollution has increased due to infrastructural development & industrialization in China & India specifically assisting the growth in asthma & allergic rhinitis

The Asia Pacific is the fastest growing segment due to key driving factors such as rising prevalence & awareness related to allergic conditions, and industrialization & infrastructural development has increased air pollution in China & India. According to the World Health Organization (WHO), there has been significant growth in the prevalence of allergic rhinitis in Asia-Pacific within the last decade that has increased the economic burden. According to experts, the key factors responsible for sudden growth in allergic rhinitis is result of changing the environment, development in hygiene & reduced infections, and increasing cases of genetic complications.

This report also covers segments including data specific to major market trends, opportunities, drivers, and restraints, to gain precise information against global allergy immunotherapy market. The key market players analyzed in the report based on major attributes such as business strength, product portfolio, and important market strategies. The report also covers an attractive investment proposition based on the in-depth geographical research executed based on PESTEL analysis. The companies profiled in the report are Hollister Stier, Leti, WOLW Pharma, Aimmune Therapeutics, ALK-Abello A/S, Stallergenes Greer, Allergopharma, DBV Technologies, Allergy Therapeutics, Biomay AG, HAL Allergy Group, Circassia, and Merck KGaA, among others.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Allergy Immunotherapy market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Allergy Immunotherapy market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Allergy

  • Food Allergy
  • Allergic Rhinitis
  • Skin Allergy
  • Insect-bite Allergy
  • Other Allergies (Drug Allergy, Eye Allergy, Latex Allergy, etc.)

Treatment

  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Allergy Immunotherapy market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Allergy Immunotherapy market?
  • Which is the largest regional market for Allergy Immunotherapy market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Allergy Immunotherapy market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Allergy Immunotherapy market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Allergy Immunotherapy Market
2.2. Global Allergy Immunotherapy Market, By Allergy, 2021 (US$ Million)
2.3. Global Allergy Immunotherapy Market, By Treatment, 2021 (US$ Million)
2.4. Global Allergy Immunotherapy Market, By Geography, 2021 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2021
3. Allergy Immunotherapy Market: Competitive Analysis
3.1. Market Positioning of Key Allergy Immunotherapy Market Vendors
3.2. Strategies Adopted by Allergy Immunotherapy Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2021 Versus 2030
4. Allergy Immunotherapy Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Allergy Immunotherapy Market Value, 2020 - 2030, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Food Allergy
5.3.2. Allergic Rhinitis
5.3.3. Skin Allergy
5.3.4. Insect-bite Allergy
5.3.5. Other Allergies (Drug Allergy, Eye Allergy, Latex Allergy, etc.)
6. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2021 Versus 2030
6.3. Market Segmentation
6.3.1. Subcutaneous Immunotherapy (SCIT)
6.3.2. Sublingual Immunotherapy (SLIT)
7. North America Allergy Immunotherapy Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
7.3. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
7.4.Allergy Immunotherapy Market: By Region, 2020-2030, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
7.4.1.1.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
7.4.1.2.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
7.4.1.3.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
8. UK and European Union Allergy Immunotherapy Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
8.3. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
8.4.Allergy Immunotherapy Market: By Region, 2020-2030, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
8.4.1.1.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
8.4.1.2.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
8.4.1.3.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
8.4.1.4.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
8.4.1.5. France
8.4.1.5.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
8.4.1.5.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
8.4.1.6.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
9. Asia Pacific Allergy Immunotherapy Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
9.3. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
9.4.Allergy Immunotherapy Market: By Region, 2020-2030, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
9.4.1.1.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
9.4.1.2.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
9.4.1.3. India
9.4.1.3.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
9.4.1.3.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
9.4.1.4.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
9.4.1.5.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
9.4.1.6.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
10. Latin America Allergy Immunotherapy Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
10.3. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
10.4.Allergy Immunotherapy Market: By Region, 2020-2030, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
10.4.1.1.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
10.4.1.2.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
10.4.1.3.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
11. Middle East and Africa Allergy Immunotherapy Market, 2020-2030, USD (Million)
11.1. Market Overview
11.2. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
11.3. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
11.4.Allergy Immunotherapy Market: By Region, 2020-2030, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
11.4.1.1.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
11.4.1.2.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
11.4.1.3.1. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
12. Company Profile
12.1. ALK-Abello A/S
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. HAL Allergy Group
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Circassia
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Aimmune Therapeutics
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Merck KGaA
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Anergis
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Biomay AG
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Stallergenes Greer
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. DBV Technologies
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Allergy Therapeutics
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
List of Figures
Figure 1 Global Allergy Immunotherapy Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Allergy Immunotherapy Market: Quality Assurance
Figure 5 Global Allergy Immunotherapy Market, By Allergy, 2021
Figure 6 Global Allergy Immunotherapy Market, By Treatment, 2021
Figure 7 Global Allergy Immunotherapy Market, By Geography, 2021
Figure 8 Market Geographical Opportunity Matrix - Global Allergy Immunotherapy Market, 2021
Figure 9 Market Positioning of Key Allergy Immunotherapy Market Players, 2021
Figure 10 Global Allergy Immunotherapy Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 11 Global Allergy Immunotherapy Market, By Allergy, 2021 Vs 2030, %
Figure 12 Global Allergy Immunotherapy Market, By Treatment, 2021 Vs 2030, %
Figure 13 U.S. Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 14 Canada Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 15 Rest of North America Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 16 UK Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 17 Germany Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 18 Spain Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 19 Italy Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 20 France Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 21 Rest of Europe Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 22 China Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 23 Japan Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 24 India Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 25 Australia Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 26 South Korea Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 27 Rest of Asia Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 28 Brazil Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 29 Mexico Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 30 Rest of Latin America Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 31 GCC Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 32 Africa Allergy Immunotherapy Market (US$ Million), 2020 - 2030
Figure 33 Rest of Middle East and Africa Allergy Immunotherapy Market (US$ Million), 2020 - 2030
List of Tables
Table 1 Global Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 2 Global Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 3 North America Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 4 North America Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 5 U.S. Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 6 U.S. Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 7 Canada Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 8 Canada Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 9 Rest of North America Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 10 Rest of North America Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 11 UK and European Union Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 12 UK and European Union Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 13 UK Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 14 UK Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 15 Germany Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 16 Germany Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 17 Spain Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 18 Spain Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 19 Italy Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 20 Italy Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 21 France Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 22 France Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 23 Rest of Europe Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 24 Rest of Europe Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 25 Asia Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 26 Asia Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 27 China Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 28 China Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 29 Japan Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 30 Japan Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 31 India Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 32 India Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 33 Australia Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 34 Australia Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 35 South Korea Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 36 South Korea Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 37 Latin America Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 38 Latin America Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 39 Brazil Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 40 Brazil Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 41 Mexico Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 42 Mexico Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 43 Rest of Latin America Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 44 Rest of Latin America Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 45 Middle East and Africa Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 46 Middle East and Africa Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 47 GCC Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 48 GCC Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 49 Africa Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 50 Africa Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
Table 51 Rest of Middle East and Africa Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
Table 52 Rest of Middle East and Africa Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)

Companies Mentioned

  • Hollister Stier
  • Leti
  • WOLW Pharma
  • Aimmune Therapeutics
  • ALK-Abello A/S
  • Stallergenes Greer
  • Allergopharma
  • DBV Technologies
  • Allergy Therapeutics
  • Biomay AG
  • HAL Allergy Group
  • Circassia
  • Merck KGaA

Related Topics

Related Reports

Global Allergy Immunotherapy Market by Type (SCIT, SLIT), Allergy Type (Allergic Rhinitis, Asthma, Food Allergy), Distribution Channel - Forecast 2024-2030 - Product Image

Global Allergy Immunotherapy Market by Type (SCIT, SLIT), Allergy Type (Allergic Rhinitis, Asthma, Food Allergy), Distribution Channel - Forecast 2024-2030

  • Report
  • 184 Pages
  • Global
From
Global Allergy Drugs Market by Type (Drug Allergy, Food Allergy, Inhaled Allergy), Treatment (Anti-allergy Drugs, Immunotherapy), Distribution Channels - Forecast 2024-2030 - Product Image

Global Allergy Drugs Market by Type (Drug Allergy, Food Allergy, Inhaled Allergy), Treatment (Anti-allergy Drugs, Immunotherapy), Distribution Channels - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Global Allergy Immunotherapy Market Analysis & Forecast to 2023-2033: Market By Type; By Application; By Distribution Channel; and By Region - Product Image

Global Allergy Immunotherapy Market Analysis & Forecast to 2023-2033: Market By Type; By Application; By Distribution Channel; and By Region

  • Report
  • 145 Pages
  • Global
From
Global Allergy Immunotherapy Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy), By Treatment Type, By Allergy Type, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Allergy Immunotherapy Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy), By Treatment Type, By Allergy Type, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 262 Pages
  • Global
From
Allergy Immunotherapy Market Report 2023-2033 - Product Image

Allergy Immunotherapy Market Report 2023-2033

  • Report
  • 187 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.